Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide

• Published in: Vaccine 2006-05, Vol.24 (22), p.4838-4846
• Main Authors: Mahmood, M.S., Siddique, M., Hussain, I., Khan, A., Mansoor, M.K.
• Format: Article
• Language: English
• Subjects: Adjuvants, Immunologic - administration & dosage; Animals; Antibodies, Viral - blood; Applied microbiology; Biological and medical sciences; Birnaviridae Infections - prevention & control; Birnaviridae Infections - veterinary; Body Weight; Chickens; CpG ODN; Deoxyribonucleic acid; DNA; DNA vaccine; Fundamental and applied biological sciences. Psychology; Human cytomegalovirus; Immune system; Immunization; Infectious bursal disease; Infectious bursal disease virus; Infectious bursal disease virus - immunology; Lymphocyte Activation; Microbiology; Miscellaneous; Oligodeoxyribonucleotides - administration & dosage; Plasmids; Poultry; Poultry Diseases - prevention & control; pRc-VP2; Recombinant plasmids; T-Lymphocytes - immunology; Vaccines; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects); Vaccines, DNA - immunology; Viral Vaccines - immunology; Virology; vvIBDV
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2006.03.016

In the present study the efficacy of recombinant plasmids DNA vaccine encoding VP2 gene of very virulent strain of infectious bursal disease virus (vvIBDV) isolated from Pakistan was investigated with or without coadministration of cytocine-phosphate-guanine oligodeoxynucleotide (CpG ODN) to protect the chickens against the disease. VP2 gene of vvIBDV was successfully amplified by reverse transcription-polymerase chain reaction (RT-PCR) and was cloned into eukaryotic expression plasmid vector, which consisted of human cytomegalovirus (HCMV) immediate early enhancer and promoter, adenopartite leader sequences and SV-40 polyadenylation signal, and this was designated as pRc-VP2. Seven-day-old maternal antibodies free chickens were intramuscularly injected with 500 μg of pRc-VP2 with or without CpG ODN twice at 1-week interval. At the age of 21 days the broiler chickens were challenged with 10 5 EID 50 of homologous strain of IBDV and observed for 14 days post-challenge. Immunization with pRc-VP2 plus CpG ODN conferred protection in 93% of the chickens as evidenced by the absence of clinical signs, atrophy of bursa of Fabricius (BF) and mortality followed by the group vaccinated with attenuated IBD vaccine and boosted with killed oil based IBDV vaccine, which conferred 90% protection. The protection of chickens injected with pRc-VP2 alone was 67% where as only 20% of the chickens in the negative control group were protected. However, enzyme-linked immunosorbent assay (ELISA) antibody titre in the group vaccinated with pRc-VP2 plus CpG ODN were significantly higher ( P < 0.05) than the group vaccinated with pRc-VP2 alone as well as the group vaccinated with commercial attenuated IBDV vaccine boosted with commercial oil adjuvanted killed IBDV vaccine. Responsiveness to a mitogenic lectin, phytoheamagglutinin-P was significantly reduced in group immunized with conventional vaccines (live boosted with killed) as compared to all the other groups ( P < 0.05). The results revealed that co-administration of recombinant plasmids with CpG ODN could protect chickens efficiently from IBDV challenge.